Status:
COMPLETED
Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
The Gillian Reny Stepping Strong Center for Trauma Innovation
Gillette Children's Specialty Healthcare
Conditions:
Traumatic Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized controlled study evaluating the ability of laypersons to correctly apply a tourniquet using different instructional methods. There are four arms being evaluated: flashcards, audio...
Detailed Description
Trauma is the number one cause of mortality in the US for individuals under 45 and uncontrolled hemorrhage is the leading cause of preventable deaths. Recent military experience has shown rapid interv...
Eligibility Criteria
Inclusion
- employees of Gillette Stadium \>18 years old
Exclusion
- participants who self-report prior hemorrhage control training will be excluded from the final analysis for tourniquet application but included in randomization
Key Trial Info
Start Date :
May 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2018
Estimated Enrollment :
562 Patients enrolled
Trial Details
Trial ID
NCT03479112
Start Date
May 22 2017
End Date
January 30 2018
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115